Researchers at Columbia University have developed an AI system that can predict gene activity in human cells with high precision. The model called GET (general expression transformer) can enhance the study of normal and diseased cells and has been successfully tested on pediatric leukemia cells. The team believe the system could revolutionise our understanding of biology and potentially speed up disease research.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
